RenovoRx, Inc. (RNXT)

NASDAQ: RNXT · Delayed Price · USD
4.10
0.04 (0.99%)
At close: Jan 18, 2022 4:00 PM
4.15
0.05 (1.22%)
After-hours:Jan 18, 2022 6:28 PM EST
Market Cap36.52M
Revenue (ttm)n/a
Net Income (ttm)-4.31M
Shares Out8.91M
EPS (ttm)-1.48
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume48,281
Open3.99
Previous Close4.06
Day's Range3.90 - 4.19
52-Week Range3.81 - 16.74
Betan/a
AnalystsBuy
Price Target15.50 (+278.0%)
Earnings Daten/a

About RNXT

RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for our lead product candidate RenovoGem. Our therapy platform, RenovoTAMP, combines our patented FDA cleared delivery system, RenovoCath®, with small molecule chemotherapeutic agents that can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. While we anticipate investigating other chemotherapeutic agents for int...

IndustryBiotechnology
IPO DateAug 26, 2021
CEOShaun Bagai
Employees10
Stock ExchangeNASDAQ
Ticker SymbolRNXT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for RenovoRx stock is "Buy." The 12-month stock price forecast is 15.50, which is an increase of 278.05% from the latest price.

Price Target
$15.50
(278.05% upside)
Analyst Consensus: Buy

News

RenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (NASDAQ: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that Shaun Bagai, Chief Executive Officer, will p...

1 week ago - Business Wire

5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile ex...

Other symbols:CRTXGRABNUZEPPSI
1 month ago - Benzinga

Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop

PPSI, NUZE, and three other stocks are ranked highly in Fintel's Short Squeeze Screener. All three names have a score higher than 96.

Other symbols:NEGGPETZNUZEPPSI
1 month ago - InvestorPlace

5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And More

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profile ...

Other symbols:NEGGNUZEPETZPPSI
1 month ago - Benzinga

RenovoRx Announces Third Quarter 2021 Financial Results

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today reported its unaudited financial results for the third quar...

2 months ago - Business Wire

RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced that it will be presenting an ePoster at the 2021...

2 months ago - Business Wire

RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today

RenovoRx (RNXT) stock is rocketing higher today thanks to a presentation of data at a medical conference yesterday evening. The post RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today appe...

2 months ago - InvestorPlace

Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy...

MIAMI & LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced its novel therapy platform, RenovoTAMPTM ...

2 months ago - Business Wire

RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today

RenovoRx (RNXT) stock is running higher on Tuesday following news that the U.S. Food and Drug Administration granted it new 501(k) clearance. The post RNXT Stock: The FDA News That Has Biotech Company R...

4 months ago - InvestorPlace

See Why RenovoRx Stock Is Shooting Higher On Tuesday

The FDA has granted a new 510(k) clearance to RenovoRx Inc's (NASDAQ:RNXT) RenovoCath Delivery System.  The RenovoCath Delivery System is the device component of the Company's initial product, RenovoGem.

4 months ago - Benzinga

RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid T...

LOS ALTOS, Calif., Sept. 7, 2021 /PRNewswire/ --  RenovoRx , Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced it has received a new 510(k) clear...

4 months ago - PRNewsWire